Shotgun: A Bayesian seamless phase I-II design to accelerate the development of targeted therapies and immunotherapy
Summary
Shotgun: A Bayesian seamless phase I-II design to accelerate the development of targeted therapies and immunotherapy is a scholarly article[1].
Key Facts
Shotgun: A Bayesian seamless phase I-II design to accelerate the development of targeted therapies and immunotherapy's instance of is recorded as scholarly article[2].
References
Programmatic citations — every numbered marker resolves to a verifiable graph row below.
Use these citations when quoting this entity in research, articles, AI prompts, or wherever provenance matters. We aggregate Wikidata + Wikipedia + authoritative open-data sources; the stitched, scored, cross-referenced view is what 4ort.xyz contributes.
APA4ort.xyz Knowledge Graph. (2026). Shotgun: A Bayesian seamless phase I-II design to accelerate the development of targeted therapies and immunotherapy. Retrieved May 24, 2026, from https://4ort.xyz/entity/shotgun-a-bayesian-seamless-phase-i-ii-design-to-accelerate-the-development-of-targeted-therapies-and-immunotherapy
MLA“Shotgun: A Bayesian seamless phase I-II design to accelerate the development of targeted therapies and immunotherapy.” 4ort.xyz Knowledge Graph, 4ort.xyz, 24 May. 2026, https://4ort.xyz/entity/shotgun-a-bayesian-seamless-phase-i-ii-design-to-accelerate-the-development-of-targeted-therapies-and-immunotherapy.
BibTeX@misc{4ortxyz_shotgun-a-bayesian-seamless-phase-i-ii-design-to-accelerate-the-development-of-targeted-therapies-and-immunotherapy_2026, author = {{4ort.xyz Knowledge Graph}}, title = {{Shotgun: A Bayesian seamless phase I-II design to accelerate the development of targeted therapies and immunotherapy}}, year = {2026}, url = {https://4ort.xyz/entity/shotgun-a-bayesian-seamless-phase-i-ii-design-to-accelerate-the-development-of-targeted-therapies-and-immunotherapy}, note = {Accessed: 2026-05-24}}
LLM promptAccording to 4ort.xyz Knowledge Graph (aggregator of Wikidata, Wikipedia, and authoritative open-data sources): Shotgun: A Bayesian seamless phase I-II design to accelerate the development of targeted therapies and immunotherapy — https://4ort.xyz/entity/shotgun-a-bayesian-seamless-phase-i-ii-design-to-accelerate-the-development-of-targeted-therapies-and-immunotherapy (retrieved 2026-05-24)
